Maki Hirao

Statistics

Publications

Citations

474

H-Index

Active since

1998

Affiliations

Fred Hutch Cancer Center(Current)

Saiseikai Central Hospital

Keio University

Maki Hirao is an author at Fred Hutch Cancer Center specializing in nicotinamide adenine dinucleotide metabolism, drug discovery, and molecular biology.

ORCID

Publications per year

1998–2023

Publications

Inhibitors of Sir2: Evaluation of Splitomicin Analogues

Jeff Posakony, Maki Hirao, S.D. Stevens et al. · Journal of Medicinal Chemistry · 2004 · 157 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

NAD+-Dependent Deacetylase Hst1p Controls Biosynthesis and Cellular NAD+ Levels in Saccharomyces cerevisiae

Antonio Bedalov, Maki Hirao, Jeff Posakony et al. · Molecular and Cellular Biology · 2003 · 136 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

Characterization of soluble E-cadherin as a disease marker in gastric cancer patients

Junji Gofuku, Hitoshi Shiozaki, Yuichiro� Doki et al. · British Journal of Cancer · 1998 · 73 citations · Full text

Medicine, Oncology, Pathology +14

Identification of Selective Inhibitors of NAD+-dependent Deacetylases Using Phenotypic Screens in Yeast

Maki Hirao, Jeff Posakony, Melisa Nelson et al. · Journal of Biological Chemistry · 2003 · 72 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

A novel homozygous variant of the thrombomodulin gene causes a hereditary bleeding disorder

Makoto Osada, Keiko Maruyama, Koichi Kokame et al. · Blood Advances · 2021 · 14 citations · Full text

Medicine, Hematology, Molecular Genetics +17

1–5 of 7